White label ELPA - ClinicalTrials.eu

Study of Cenegermin Nasal Spray for Safety and Tolerability in Children with Spastic Cerebral Palsy

Recruiting

2 1
Investigated Drugs:
- Cenegermin
Comparing 1-Minute and 5-Minute Poractant Alfa Treatment for Respiratory Distress Syndrome in Very Premature Babies Born Before 28 Weeks

Recruiting

3 1 1 1
Investigated Diseases:
- Neonatal respiratory distress syndrome
Investigated Drugs:
- Poractant Alfa
A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

Recruiting

3 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- BLEXIMENIB
+8
Testing 18F-DPA-714 PET scan as a marker of brain inflammation in patients with autoimmune encephalitis

Recruiting

2 1 1
Investigated Diseases:
- Encephalitis autoimmune
A Study Testing How Well Faricimab Works in Patients with Subretinal Hyperreflective Material Associated with Neovascular Membranes in the Eye

Recruiting

3 1 1 1
Investigated Diseases:
- Eye disorder
Investigated Drugs:
- Faricimab
Study of GS-4321 for Healthy People and Patients With Chronic Hepatitis Delta Virus Infection

Recruiting

2 1
Investigated Diseases:
- Hepatitis D
Investigated Drugs:
- GS-4321
Study of TranspoCART19 cell therapy for patients with CD19-positive acute lymphoblastic leukemia that is resistant or refractory to treatment

Recruiting

1 1 1
Investigated Diseases:
- Acute lymphocytic leukaemia
Investigated Drugs:
- Transpocart19
A study comparing prasinezumab with placebo for people with early-stage Parkinson’s disease

Recruiting

3 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- Prasinezumab
+3
Study of Surabgene Lomparvovec Compared to Ranibizumab for Adults with Wet Age-Related Macular Degeneration

Recruiting

3 1 1 1
Investigated Drugs:
- Ranibizumab
+7
A Study of Orforglipron for Knee Pain Relief in Adults with Obesity or Overweight and Knee Osteoarthritis

Recruiting

3 1
Investigated Diseases:
- Osteoarthritis

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies